MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 186 filers reported holding MYRIAD GENETICS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,338 | -0.2% | 144 | 0.0% | 0.00% | – |
| Q1 2023 | $3,345 | -99.8% | 144 | -99.7% | 0.00% | -100.0% |
| Q2 2015 | $1,936,000 | 0.0% | 56,952 | +4.1% | 0.07% | +1.5% |
| Q1 2015 | $1,936,000 | +27.6% | 54,703 | +22.8% | 0.06% | +25.0% |
| Q4 2014 | $1,517,000 | -34.8% | 44,548 | -26.2% | 0.05% | -33.3% |
| Q3 2014 | $2,327,000 | -33.6% | 60,337 | -32.9% | 0.08% | -30.4% |
| Q2 2014 | $3,502,000 | +26.5% | 89,968 | +11.1% | 0.11% | +21.7% |
| Q1 2014 | $2,769,000 | +81.8% | 80,977 | +11.6% | 0.09% | +80.4% |
| Q4 2013 | $1,523,000 | +25.9% | 72,572 | +41.0% | 0.05% | +15.9% |
| Q3 2013 | $1,210,000 | +228.8% | 51,476 | +276.1% | 0.04% | +214.3% |
| Q2 2013 | $368,000 | – | 13,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |